ACM
GRCE

ADAR1 Capital Management’s Grace Therapeutics GRCE Stock Holding History

ADAR1 Capital Management’s Portfolio GRCE Stock Details GRCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-641,988
Closed -$2.22M – 356
2025
Q4 		$2.22M Buy
641,988
+291,538
+83% +$926K 0.17% 96
2025
Q3 		$1.04M Buy
350,450
+173,823
+98% +$545K 0.1% 99
2025
Q2 		$525K Sell
176,627
-166,885
-49% -$444K 0.09% 114
2025
Q1 		$783K Sell
343,512
-430,123
-56% -$1.36M 0.15% 88
2024
Q4 		$2.89M Sell
773,635
-185,936
-19% -$637K 0.6% 38
2024
Q3 		$2.88M Hold
959,571
– – 0.48% 40
2024
Q2 		$2.8M Buy
959,571
+742,190
+341% +$2.24M 0.56% 31
2024
Q1 		$745K Buy
217,381
+182,849
+530% +$539K 0.2% 71
2023
Q4 		$99.8K Buy
+34,532
New +$81.8K 0.04% 95

Other funds holding GRCE

Cerity Partners
Cerity Partners New York $70.5B AUM 21.68% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return